PRESS RELEASE
News
-
-
PRESS RELEASE
EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights -
-
-
-
-
-
-
PRESS RELEASE
Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
Transgene and BioInvent present promising early results of oncolytic virus BT-001 in ESMO 2024, showing antitumor activity in solid tumors. BT-001 induces tumor regression and enhances T cell infiltration -
PRESS RELEASE
Rektron Announces Successful IPO and Begins Trading on the Canadian Securities Exchange, Frankfurt Stock Exchange and Tradegate Exchange and Corporate Updates
Rektron Group Inc. successfully completes IPO on CSE, FSE, and TE. Appoints new COO and receives requisition for a special meeting. Engages MACA and ITG for market services
